American Portfolios Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $57.7K | Sell |
3,938
-742
| -16% | -$10.9K | ﹤0.01% | 1616 |
|
|
2022
Q2 | $71.1K | Hold |
4,680
| – | – | ﹤0.01% | 1577 |
|
|
2022
Q1 | $84.2K | Sell |
4,680
-137
| -3% | -$2.47K | ﹤0.01% | 1607 |
|
|
2021
Q4 | $115K | Sell |
4,817
-890
| -16% | -$21.2K | ﹤0.01% | 1446 |
|
|
2021
Q3 | $173K | Sell |
5,707
-365
| -6% | -$11.1K | 0.01% | 1181 |
|
|
2021
Q2 | $194K | Hold |
6,072
| – | – | 0.01% | 1114 |
|
|
2021
Q1 | $182K | Buy |
6,072
+23
| +0.4% | +$688 | 0.01% | 1066 |
|
|
2020
Q4 | $192K | Sell |
6,049
-40
| -0.7% | -$1.27K | 0.01% | 897 |
|
|
2020
Q3 | $167K | Hold |
6,089
| – | – | 0.01% | 867 |
|
|
2020
Q2 | $165K | Sell |
6,089
-216
| -3% | -$5.85K | 0.01% | 805 |
|
|
2020
Q1 | $123K | Sell |
6,305
-1,419
| -18% | -$27.7K | 0.01% | 823 |
|
|
2019
Q4 | $181K | Sell |
7,724
-3,787
| -33% | -$88.8K | 0.01% | 774 |
|
|
2019
Q3 | $216K | Sell |
11,511
-99
| -0.9% | -$1.86K | 0.02% | 686 |
|
|
2019
Q2 | $245K | Buy |
11,610
+246
| +2% | +$5.19K | 0.02% | 629 |
|
|
2019
Q1 | $239K | Sell |
11,364
-69
| -0.6% | -$1.45K | 0.02% | 584 |
|
|
2018
Q4 | $216K | Sell |
11,433
-3,465
| -23% | -$65.4K | 0.03% | 491 |
|
|
2018
Q3 | $370K | Buy |
14,898
+23
| +0.2% | +$571 | 0.04% | 398 |
|
|
2018
Q2 | $359K | Buy |
14,875
+4,991
| +50% | +$120K | 0.05% | 363 |
|
|
2018
Q1 | $287K | Sell |
9,884
-72
| -0.7% | -$2.09K | 0.04% | 392 |
|
|
2017
Q4 | $237K | Buy |
+9,956
| New | +$237K | 0.04% | 444 |
|